德賽電池(000049.SZ):控股股東進行存續分立事項已取得必要的國有資產監管機構批准
格隆匯 9 月 15日丨德賽電池(000049.SZ)公佈,2020年7月21日,公司披露了公告編號為2020—025的《關於控股股東擬進行分立的提示性公告》。為進一步深化國有企業改革,公司控股股東廣東德賽集團有限公司(“德賽集團”)擬進行存續分立,德賽集團將分立成為德賽集團(存續公司)和新設公司(尚待命名)。
2020年9月15日,公司收到控股股東德賽集團的書面通知函,此次分立事項已取得必要的國有資產監管機構批准,所獲批準情況與公告編號為2020—025的《關於控股股東擬進行分立的提示性公告》的內容一致。後續,德賽集團將根據相關批准積極推進本次分立事項。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.